LMC | Manna Research will be at the 8th Annual SCOPE Summit in Miami, FL

LMC | Manna Research will be at the 8th Annual SCOPE Summit in Miami, FL

LMC | Manna Research’s Karri Venn (President, Research), will be at the 8th Annual SCOPE Summit in Miami, FL from January 24th-26th 2017. If you are interested to connect while we are in Miami, please use the information listed below to schedule a meeting: Karri Venn Incoming Calls: 647-274-4133 Text Messaging (at the conference): 815-919-6396 karri.venn@LMC.ca Looking forward to connect in Miami! #SCOPE2017...
GSK Shingles Vaccine Remains Effective After Four Years: Study

GSK Shingles Vaccine Remains Effective After Four Years: Study

GlaxoSmithKline’s experimental vaccine to prevent the intensely painful condition known as shingles remained 90 percent effective in people over age 70 even four years after receiving the injection, according to data published on Wednesday. In clinical trials, GSK’s Shingrix has shown greater protection for older recipients than what has been demonstrated by Merck & Co’s rival Zostavax vaccine. The drug is one of GSK’s biggest new product hopes. It plans to file for U.S., European and Japanese approval this year, and the vaccine could reach the market in 2017. The latest four-year data on Shingrix, which appears in the New England Journal of Medicine, shows it may also provide an additional significant advantage by maintaining its effectiveness over time. The risk of shingles, which is caused by reactivation of the chicken pox virus, increases with age. There are about 1 million cases of shingles in the United States each year, according to the Centers for Disease Control and Prevention. To read more from this article, please click...
Herpes Zoster Subunit Vaccine Shows Great Efficacy in Adults 70 and Older

Herpes Zoster Subunit Vaccine Shows Great Efficacy in Adults 70 and Older

Great news in the world of vaccines! In the ZOE-70 Study, the herpes zoster subunit vaccine (HZ/su) was showed to decrease the risk of herpes zoster by 89.8% in adults 70 years of age and older. Herpes zoster, or shingles, results from the reactivation of latent varicella–zoster virus (VZV) and is recognized as a painful rash on the skin (postherpetic neuralgia). It also affects nerve fibers , causing burning pain that lasts long after the rash and blisters of shingles disappear. See the video below to learn more about this study and some of the exciting results! To read more about this trial click here...
LMC Diabetes & Endocrinology’s Presents Type 2 Diabetes Findings at #EASD2016 in Munich, Germany

LMC Diabetes & Endocrinology’s Presents Type 2 Diabetes Findings at #EASD2016 in Munich, Germany

During the week of September 12th – 16th, 2016, LMC Diabetes & Endocrinology’s Dr. Ronnie Aronson and Dr. Harpreet Bajaj were present at the 52nd EASD Annual Meeting hosted by the European Association for the Study of Diabetes in Munich, Germany. The EASD is a non-profit association of scientists, physicians, laboratory workers, nurses and students who are interested in diabetes and related subjects. Not only did both of LMC’s endocrinologists have key information to share via poster presentations, Dr. Bajaj also gave an oral presentation titled:Canagliflozin and dapagliflozin, but not liraglutide, reduce Alanine Aminotransferase (ALT) levels in type 2 diabetes: a difference not explained by HbA1c or weight change. To view this presentation, click here: http://m.easdvirtualmeeting.org/#Presentations/29238/Webcast To learn more about LMC, visit their website...